Singapore: Regeneron Pharmaceuticals and Sanofi have been asked by the US FDA to assess potential neurocognitive side ef...
Singapore: Taiwan-based TWi Biotechnology has received notification of patent allowance for AC-201, its lead drug candid...
Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging a...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Despite concerns around declines in R&D, there would be a surge in global sales in the coming years reach...
Singapore: Amaran Biotechnology is going to invest $33.41 million (NT$1 billion) in order to construct a plant and a res...
Singapore: Australia-based Drawbridge Pharmaceuticals has commenced a phase 1C clinical trial of alphaxalone dissolved i...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pat...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: ChemoCentryx reported that GlaxoSmithKline's (GSK) first-of-four phase III studies, called Shield-1; investig...
Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...
Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...
